4.7 Article

The development of a pregnancy PBPK Model for Bisphenol A and its evaluation with the available biomonitoring data

期刊

SCIENCE OF THE TOTAL ENVIRONMENT
卷 624, 期 -, 页码 55-68

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.scitotenv.2017.12.023

关键词

Bisphenol A; Pregnancy-PBPK; Fetal exposure; Biomonitoring; Window of exposure

资金

  1. European Union's project, EuroMix (European Test and Risk Assessment Strategies for Mixtures) by the Horizon Framework Programme [633172]
  2. European Unionapos
  3. s project, HEALS (Health and Environment-wide Associations via Large population Surveys) by the FP7 Programme [603946]
  4. Universitat Rovira i Virgili under Marti-Franques Research Grants Programme

向作者/读者索取更多资源

Recent studies suggest universal fetal exposure to Bisphenol A (BPA) and its association with the adverse birth outcomes. Estimation of the fetal plasma BPA concentration from the maternal plasma BPA would be highly useful to predict its associated risk to this specific population. The objective of current work is to develop a pregnancy-physiologically based pharmacokinetic (P-PBPK) model to predict the toxicokinetic profile of BPA in the fetus during gestational growth, and to evaluate the developed model using biomonitoring data obtained from different pregnancy cohort studies. To achieve this objective, first, the adult PBPK model was developed and validated with the human BPA toxicokinetic data. This validated human PBPK model was extended to develop a P-PBPK model, which included the physiological changes during pregnancy and the fetus sub-model. The developed model would be able to predict the BPA pharmacokinetics (PKs) in both mother and fetus. Transplacental BPA kinetics parameters for this study were taken from the previous pregnant mice study. Both oral and dermal exposure routes were included into the model to simulate total BPA internal exposure. The impact of conjugation and deconjugation of the BPA and its metabolites on fetal PKs was investigated. The developed P-PBPK model was evaluated against the observed BPA concentrations in cord blood, fetus liver and amniotic fluid considering maternal blood concentration as an exposure source. A range of maternal exposure dose for the oral and dermal routes was estimated, so that simulation concentration matched the observed highest and lowest mother plasma concentration in different cohorts* studies. The developed model could be used to address the concerns regarding possible adverse health effects in the fetus being exposed to BPA and might be useful in identifying critical windows of exposure during pregnancy. (C) 2017 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据